217 related articles for article (PubMed ID: 11732641)
1. An approach for the rational design of new antituberculosis agents.
Pasqualoto KF; Ferreira EI
Curr Drug Targets; 2001 Dec; 2(4):427-37. PubMed ID: 11732641
[TBL] [Abstract][Full Text] [Related]
2. Current status and future development of antitubercular chemotherapy.
Kremer LS; Besra GS
Expert Opin Investig Drugs; 2002 Aug; 11(8):1033-49. PubMed ID: 12150700
[TBL] [Abstract][Full Text] [Related]
3. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
6. Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis.
Bhat ZS; Rather MA; Maqbool M; Lah HU; Yousuf SK; Ahmad Z
Biomed Pharmacother; 2017 Nov; 95():1520-1534. PubMed ID: 28946393
[TBL] [Abstract][Full Text] [Related]
7. Assembly of the Mycobacterial Cell Wall.
Jankute M; Cox JA; Harrison J; Besra GS
Annu Rev Microbiol; 2015; 69():405-23. PubMed ID: 26488279
[TBL] [Abstract][Full Text] [Related]
8. Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
Cavalier JF; Spilling CD; Durand T; Camoin L; Canaan S
Eur J Med Chem; 2021 Jan; 209():112908. PubMed ID: 33071055
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in
Kim S; Seo H; Mahmud HA; Islam MI; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
J Microbiol Biotechnol; 2017 Nov; 27(11):1932-1941. PubMed ID: 28870005
[TBL] [Abstract][Full Text] [Related]
10. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.
Bailo R; Bhatt A; Aínsa JA
Biochem Pharmacol; 2015 Aug; 96(3):159-67. PubMed ID: 25986884
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis.
de Souza MV; Ferreira Mde L; Pinheiro AC; Saraiva MF; de Almeida MV; Valle MS
ScientificWorldJournal; 2008 Jul; 8():720-51. PubMed ID: 18677428
[TBL] [Abstract][Full Text] [Related]
12. Altered drug efflux under iron deprivation unveils abrogated MmpL3 driven mycolic acid transport and fluidity in mycobacteria.
Pal R; Hameed S; Fatima Z
Biometals; 2019 Feb; 32(1):49-63. PubMed ID: 30430296
[TBL] [Abstract][Full Text] [Related]
13. [Biosynthesis and regulation of mycolic acids in Mycobacterium tuberculosis--a review].
Luo H; Pang L; Xie J
Wei Sheng Wu Xue Bao; 2012 Feb; 52(2):146-51. PubMed ID: 22586991
[TBL] [Abstract][Full Text] [Related]
14.
Taira J; Ito T; Nakatani H; Umei T; Baba H; Kawashima S; Maruoka T; Komatsu H; Sakamoto H; Aoki S
Int J Mycobacteriol; 2017; 6(2):142-148. PubMed ID: 28559515
[TBL] [Abstract][Full Text] [Related]
15. New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.
North EJ; Jackson M; Lee RE
Curr Pharm Des; 2014; 20(27):4357-78. PubMed ID: 24245756
[TBL] [Abstract][Full Text] [Related]
16. Approaches to the development of new antituberculosis drugs.
Sensi P
Rev Infect Dis; 1989; 11 Suppl 2():S467-70. PubMed ID: 2496458
[TBL] [Abstract][Full Text] [Related]
17. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches.
Bueno RV; Braga RC; Segretti ND; Ferreira EI; Trossini GH; Andrade CH
Curr Pharm Des; 2014; 20(27):4474-85. PubMed ID: 24245758
[TBL] [Abstract][Full Text] [Related]
18. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
[No Abstract] [Full Text] [Related]
19. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
20. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
